CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Annual Report and Accounts

09/07/2007 12:20pm

UK Regulatory

RNS Number:8840Z
Celsis International PLC
09 July 2007



                             CELSIS INTERNATIONAL PLC
                           ("Celsis" or "the Company")

                             Annual Report & Accounts

9 July 2007: Celsis International plc, the life sciences products and laboratory
services company, today announces that copies of the Company's Annual Report and
Accounts 2007 have been submitted to the UK Listing Authority (UKLA) and will
shortly be delivered for inspection at the UKLA Document Viewing Facility, which
is situated at:


Financial Services Authority

25 The North Colonnade

London

E14 5HS

020 7066 1000



For further information please contact:


Celsis International plc

Tel: 01223 598 428

Christian Madrolle, Finance Director & Company Secretary

Jenny Parsons, Corporate Communications



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

ACSBBGDRLBGGGRC